← Leaderboards
Scott A. Tibbetts
University Of Florida
$9,656,998
Attributed
$9,656,998
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,656,998 · 11
By mechanism
R01$5,621,209 · 3
P01$3,553,439 · 5
P20$482,350 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Erik K Flemington$23,678,004
- Rolf F Renne$15,821,379
- Lauren Appleby Gay$102,690
Others in their field
Top investigators on “Gammaherpesvirus”
- Samuel H Speck · Washington University$20,020,071
- Erle S Robertson · University Of Michigan At Ann Arbor$15,076,657
- Edward John Usherwood · Dartmouth College$12,572,685
- Ren Sun · University Of California Los Angeles$10,243,249
- Kenneth M Kaye · Brigham And Women'S Hospital$10,075,849
- Britt A Glaunsinger · University Of California Berkeley$9,742,408
Research focus
GammaherpesvirusInfectionHuman Herpesvirus 8VirusHuman Herpesvirus 4In VivoB-LymphocytesPreventMalignant NeoplasmsLatent InfectionViralMolecularDefined ContributionLinkMalignant - DescriptorBiologyBiologicalHerpesviridaeUntranslated RnaLymphomaImmunocompromised HostMicrornasEventInfected B Cell
Grant awards (33)
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis$450,205
R01 · FY2025 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$214,547
P01 · FY2025 · CA · contact PI
"Core D" Clinical Sample and Tumorigenesis Core$214,544
P01 · FY2025 · CA · contact PI
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis$426,328
R01 · FY2024 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$293,168
P01 · FY2024 · CA · contact PI
"Core D" Clinical Sample and Tumorigenesis Core$216,886
P01 · FY2024 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$76,753
P01 · FY2024 · CA · contact PI
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis$447,456
R01 · FY2023 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$299,949
P01 · FY2023 · CA · contact PI
"Core D" Clinical Sample and Tumorigenesis Core$222,237
P01 · FY2023 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$46,808
P01 · FY2023 · CA · contact PI
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis$437,340
R01 · FY2022 · CA · contact PI
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis$300,215
P01 · FY2022 · CA · contact PI
"Core D" Clinical Sample and Tumorigenesis Core$219,600
P01 · FY2022 · CA · contact PI
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis$445,184
R01 · FY2021 · CA · contact PI
"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis$298,359
P01 · FY2021 · CA · contact PI
"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis$298,359
P01 · FY2020 · CA · contact PI
Role of MHV68 miRNAs in latencyand pathogenesis$389,360
R01 · FY2019 · AI · contact PI
"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis$289,409
P01 · FY2019 · CA · contact PI
Role of MHV68 miRNAs in latencyand pathogenesis$417,433
R01 · FY2018 · AI · contact PI
"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis$307,212
P01 · FY2018 · CA · contact PI
Role of MHV68 miRNAs in latencyand pathogenesis$396,236
R01 · FY2017 · AI · contact PI
"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis$255,393
P01 · FY2017 · CA · contact PI
Role of MHV68 miRNAs in latencyand pathogenesis$390,515
R01 · FY2016 · AI · contact PI
Role of MHV68 miRNAs in latencyand pathogenesis$364,230
R01 · FY2015 · AI · contact PI
Role of gammaherpesvirus lytic replication-associated genes in the establishment$286,022
R01 · FY2014 · CA · contact PI
Role of gammaherpesvirus lytic replication-associated genes in the establishment$277,176
R01 · FY2013 · CA · contact PI
Role of gammaherpesvirus lytic replication-associated genes in the establishment$294,868
R01 · FY2012 · CA · contact PI
Role of gammaherpesvirus lytic replication-associated genes in the establishment$294,868
R01 · FY2011 · CA · contact PI
LSUHSC COBRE: DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY$61,170
P20 · FY2011 · RR · contact PI
Role of gammaherpesvirus lytic replication-associated genes in the establishment$303,988
R01 · FY2010 · CA · contact PI
LSUHSC COBRE: DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY$209,863
P20 · FY2010 · RR · contact PI
LSUHSC COBRE: DEFINING BONE MARROW AS A RESERVOIR FOR GAMMAHERPESVIRUS LATENCY$211,317
P20 · FY2009 · RR · contact PI